Skip to main content
    A

    AN2 Therapeutics Inc (ANTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $4.47
    -0.08 (-1.76%)

    Market Cap: $172.64M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    AN2 Therapeutics Inc (ANTX) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect AN2 Therapeutics (ANTX) to earn -$0.81 per share in the fiscal year ending Dec 31, 2026. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$0.77.

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a smaller loss.

    Fiscal year ending Dec 31, 2026
    -$0.81
    EPS consensus
    Fiscal year ending Dec 31, 2027
    -$0.77
    EPS consensus
    Next report
    Mar 15, 2027
    Estimated

    EPS range

    Fiscal year endingEPS consensusEPS rangeEPS analysts
    Dec 31, 2026-$0.81-$0.81 to -$0.811
    Dec 31, 2027-$0.77-$0.80 to -$0.732

    Quarterly Estimates

    The EPS consensus rises from -$0.24 for the quarter ending Dec 31, 2026 to -$0.19 for the quarter ending Mar 31, 2027.

    EPS range

    Quarter endingEPS consensusEPS rangeEPS analysts
    Dec 31, 2026-$0.24-$0.25 to -$0.224
    Mar 31, 2027-$0.19-$0.19 to -$0.191

    Estimate Revisions

    PeriodUp 30 daysDown 30 days
    Quarter ending Mar 31, 202700

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$0.93.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$0.81-$0.90-$0.90-$0.90-$0.93N/A
    Fiscal year ending Dec 31, 2027-$0.77-$0.80-$0.80-$0.80-$0.89N/A
    Quarter ending Mar 31, 2027-$0.19-$0.21-$0.21-$0.21N/AN/A

    Frequently Asked Questions About ANTX

    What is the ANTX stock forecast?

    Consensus analyst estimates put AN2 Therapeutics's EPS at -$0.81 for the fiscal year ending Dec 31, 2026.

    What EPS do analysts expect from ANTX next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.81, with estimates from -$0.81 to -$0.81 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.77, with estimates from -$0.80 to -$0.73 from 2 analysts.

    How many analysts cover ANTX?

    1 analyst estimates EPS for AN2 Therapeutics for the fiscal year ending Dec 31, 2026.